Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Camblong JurgiDirector, Chief Executive Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $45K 8,500 sh | Jun 11, 2026 |
| 6 | Reynoso Jamie L.CEO, Medicare Advantage |  CLOVCLOVER HEALTH INVESTMENTS, CORP. /DEOpen-market sale · 10b5-1 plan | SELL | $36K 7,289 sh | Jun 11, 2026 traded Jun 11, 2026 |
| 6 | Feeley KevinCHIEF FINANCIAL OFFICER |  WGSGeneDx Holdings Corp.Option exercise | M | — 2,462 sh | Jun 11, 2026 traded Jun 9, 2026 |
| 5 | Cummings MarthaDirector |  MQMarqeta, Inc.Option exercise | M | — 36.3K sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Piekos BrianChief Financial Officer |  KALVKalVista Pharmaceuticals, Inc.Disposition to issuer | D | — 93.8K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Atkinson NajumaDirector | MQMarqeta, Inc. Option exercise | M | — 36.3K sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Audhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 68.8K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Audhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 40.0K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 21.7K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Sweet Alan JeffreyDirector |  NKSHNATIONAL BANKSHARES INCGrant or award | A | — 221 sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Paul ElaineDirector | MQMarqeta, Inc. Option exercise | M | — 36.3K sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 59.3K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Riese Phillip JohnDirector |  RELYRemitly Global, Inc.Option exercise | M | — 9,533 sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 40.0K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Schall Thomas J.Director |  IMRXImmuneering CorpGrant or award | A | — 33.4K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Paul ElaineDirector | MQMarqeta, Inc. Grant or award | A | — 52.2K sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Piekos BrianChief Financial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 55.0K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Atkinson NajumaDirector | MQMarqeta, Inc. Grant or award | A | — 52.2K sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Feinberg PeterDirector | IMRXImmuneering Corp Grant or award | A | — 33.4K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Audhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 25.8K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 93.8K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Cummings MarthaDirector | MQMarqeta, Inc. Grant or award | A | — 52.2K sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Gray Jonice MDirector |  VACMARRIOTT VACATIONS WORLDWIDE CorpGrant or award | A | — 118 sh | Jun 11, 2026 traded Jun 10, 2026 |
| 5 | Audhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 150.3K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Sweeny NicoleChief Commercial Officer | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 68.8K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Mirshekari Ali JohnDirector |  STSensata Technologies Holding plcTax withholding | F | $22K 439 sh | Jun 11, 2026 traded Jun 9, 2026 |
| 5 | Wright Robert G.EVP |  DKDelek US Holdings, Inc.Tax withholding | F | $48K 1,024 sh | Jun 11, 2026 traded Jun 9, 2026 |
| 5 | Audhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 93.8K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 5 | Audhya Paul K.CHIEF MEDICAL OFFICER | KALVKalVista Pharmaceuticals, Inc. Disposition to issuer | D | — 100.0K sh | Jun 11, 2026 traded Jun 11, 2026 |
| 4 | Neville Patrick SeanDirector | CRCLCircle Internet Group, Inc. Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jun 11, 2026 traded Jun 9, 2026 |
| 4 | Noci DarleneChief Development Officer |  NUVLNuvalent, Inc.Option exercise · 10b5-1 plan | M | — 9,315 sh | Jun 11, 2026 traded Jun 9, 2026 |
| 1 | Remer Eric RichardDirector, Chief Executive Officer |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $106K 11.7K sh | Jun 11, 2026 traded Jun 9, 2026 |
| 1 | Remer Eric RichardDirector, Chief Executive Officer | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $69K 7,517 sh | Jun 11, 2026 traded Jun 10, 2026 |
| 0 | Noci DarleneChief Development Officer | NUVLNuvalent, Inc. Option exercise · 10b5-1 plan | M | $4,720 685 sh | Jun 11, 2026 traded Jun 9, 2026 |
| 0 | Noci DarleneChief Development Officer | NUVLNuvalent, Inc. Option exercise · 10b5-1 plan | M | — 685 sh | Jun 11, 2026 traded Jun 9, 2026 |
| 0 | Noci DarleneChief Development Officer | NUVLNuvalent, Inc. Option exercise · 10b5-1 plan | M | $176K 9,315 sh | Jun 11, 2026 traded Jun 9, 2026 |
| 0 | Neville Patrick SeanDirector | CRCLCircle Internet Group, Inc. Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jun 11, 2026 traded Jun 9, 2026 |
| 0 | Noci DarleneChief Development Officer | NUVLNuvalent, Inc. Option exercise · 10b5-1 plan | M | — 10.0K sh | Jun 11, 2026 traded Jun 9, 2026 |